FDA Approved: LOTEPREDNOL ETABONATE AND TOBRAMYCIN — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals' original ANDA for Loteprednol etabonate and tobramycin ophthalmic suspension, a combination eye drop for ocular inflammati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis
• Ocular Inflammation

Drugs mentioned

• Loteprednol etabonate and tobramycin (Loteprednol etabonate and tobramycin)

Snippet

ORIG AP for LOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE AND TOBRAMYCIN)